Tamoxifen and oestrogen both protect the rat muscle against physiological damage.
Tamoxifen (TX), an oestrogen antagonist, was used to characterize the protective effect of oestradiol (E2) on exercise-related creatine kinase (CK) release from skeletal muscle of the rat. Subcutaneous administration of TX for 3 weeks in female rats had a profound antioestrogen effect as evidenced by a reduced weight of the uterus. The CK release after electrical stimulation of the isolated soleus muscle, previously shown to be E2-dependent, was markedly reduced (30-50%) after treatment with TX; this observation points to an E2-like protective action of TX instead of E2-antagonism. This effect was dose-dependent (0.25-1.00 mg/kg) and was not seen when TX was given shortly (24 h) before the experiments. In ovariectomized females, that show more CK leakage due to the lack of circulating E2, both E2- and TX-treatment resulted in a 60% reduction of the CK leakage. Muscles from male rats, treated with TX, showed a similar response: after contractions the CK release was significantly lower. We conclude that TX, like E2, reduces contraction-induced muscle damage in the rat and, thus, has E2-agonistic properties on skeletal rat muscle.
Koot
R W
RW
Department of Neurology, University of Utrecht, The Netherlands.
Amelink
G J
GJ
Blankenstein
M A
MA
Bär
P R
PR
D000818:Animals; D003402:Creatine Kinase / Q000378:metabolism; D004558:Electric Stimulation; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D009132:Muscles / Q000502:physiology*; D009929:Organ Size / Q000187:drug effects; D010052:Ovariectomy; D005082:Physical Exertion; D051381:Rats; D013629:Tamoxifen / Q000494:pharmacology*; D014599:Uterus / Q000033:anatomy & histology
D013629:Tamoxifen; D004958:Estradiol; D003402:Creatine Kinase